Please use this identifier to cite or link to this item:
Title: Probiotics, gut microbiome, and cardiovascular diseases: An update
Authors: Dosh, Laura
Ghazi, Maya
Haddad, Karim
El Masri, Jad
Hawi, Jihad 
Leone, Angelo
Basset, Charbel
Geagea, Alice Gerges
Jurjus, Rosalyn
Jurjus, Abdo
Affiliations: Faculty of Medicine 
Keywords: Atherosclerosis
Cardiovascular disease
Gut metabolites
Gut microbiota
Issue Date: 2024-01-21
Publisher: Elsevier
Part of: Transplant Immunology
Volume: 83
Cardiovascular diseases (CVD) are one of the most challenging diseases and many factors have been demonstrated to affect their pathogenesis. One of the major factors that affect CVDs, especially atherosclerosis, is the gut microbiota (GM). Genetics play a key role in linking CVDs with GM, in addition to some environmental factors which can be either beneficial or harmful. The interplay between GM and CVDs is complex due to the numerous mechanisms through which microbial components and their metabolites can influence CVDs. Within this interplay, the immune system plays a major role, mainly based on the immunomodulatory effects of microbial dysbiosis and its resulting metabolites. The resulting modulation of chronic inflammatory processes was found to reduce the severity of CVDs and to maintain cardiovascular health. To better understand the specific roles of GM-related metabolites in this interplay, this review presents an updated perspective on gut metabolites related effects on the cardiovascular system, highlighting the possible benefits of probiotics in therapeutic strategies.
ISSN: 09663274
DOI: 10.1016/j.trim.2024.102000
Open URL: Link to full text
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record

Record view(s)

checked on May 25, 2024

Google ScholarTM


Dimensions Altmetric

Dimensions Altmetric

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.